Trials / Unknown
UnknownNCT04507945
Stablishment of Prevention and Treatment System for Intestinal Dysfunction
The Goal-direct Treatment of Chronic Bowel Dysfunction
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Nanjing University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Dysfunction and intestinal endocrine dysfunction. This project will use genomics, metabonomics, microbiome and other omics techniques to study the clinical pathway of CID integrated therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nutritional Therapy, Metabolic Disorder, Regular | According to the result reported by Byrne, Wilmore, etc. in 1992 \~ 1995, the use of growth hormone, glutamine, modified diet and other measures proposed intestinal rehabilitation treatment. Then, check the patient's quality of life survey, nutritional status, inflammation indicators and other changes every three months, and use metabolomics and microbiomic tools to detect changes in the patient's nutritional metabolism, intestinal microecology, etc., and adjust the patient's nutritional treatment and microecological treatment based on the results Program. |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2021-09-30
- Completion
- 2023-09-30
- First posted
- 2020-08-11
- Last updated
- 2020-08-11
Source: ClinicalTrials.gov record NCT04507945. Inclusion in this directory is not an endorsement.